BioCentury Presents: The BioCentury Forum

Charting a newer, faster path for the U.S. in first-in-human trials​

As China raises the bar on First-in-Human trials, the U.S. faces the need to adapt, fast. The BioCentury Forum convenes 50 leaders from across the biopharma ecosystem for one day of candid, Chatham House debate on the policy and regulatory changes that can make the U.S. remain competitive and meet drugmakers needs in first-in-human trials.​

* Attendance is by invitation only.
To learn more, email conferences@biocentury.com​

Event Highlights:

  • Invite-only roundtable debate under Chatham House rules​
  • Sixth “Bending the Curve” dinner the evening before​
  • Closing networking reception

forum_cal-whitepaper.png